Pfizer makes R&D leadership changes
This article was originally published in Scrip
Executive Summary
Pfizer has promoted two R&D executives: Dr Michael Ehlers has been promoted to senior vice-president and head of BioTherapeutics R&D, and site head for Pfizer's Cambridge and Boston, Massachusetts locations in the US; and John Lin will take on the role of senior vice-president and chief scientific officer of Rinat (Pfizer’s biotech unit in California).